Kevin McKernan announced Thursday his team has sequenced the entire genome of the cannabis plant. His company is making the data public.
McKernan hopes researchers can find ways to maximize the plant's medicinal benefits while minimizing its mind-numbing effects. The project could lead to new ways to treat pain and inflammatory diseases.